Chemical Properties of 4-(5-Ethylquinuclidine-2-carbonyl)-1,2-dihydro-2-oxoquinoline

4-(5-Ethylquinuclidine-2-carbonyl)-1,2-dihydro-2-oxoquinoline

PDF Excel Molecule Calculator
InChI
InChI=1S/C19H22N2O2/c1-2-12-11-21-8-7-13(12)9-17(21)19(23)15-10-18(22)20-16-6-4-3-5-14(15)16/h3-6,10,12-13,17H,2,7-9,11H2,1H3,(H,20,22)
InChI Key
CEPOUTOVISPBIE-UHFFFAOYSA-N
Formula
C19H22N2O2
SMILES
CCC1CN2CCC1CC2C(=O)c1cc(=O)[nH]c2ccccc12
Molecular Weight1
310.39
Cheméo is a service of Céondo GmbH, since 2007, we provide simulation, modelling and software development services for the industry. Do not hesitate to contact us for your projects.

Physical Properties

Property Value Unit Source
log10WS -3.91 Crippen Calculated Property
logPoct/wat 2.349 Crippen Calculated Property
McVol 241.030 ml/mol McGowan Calculated Property
Inp [2552.00; 2552.00]   Show Hide
Inp 2552.00 NIST
Inp 2552.00 NIST

Similar Compounds

Vobassan-17-oic acid, 4-demethyl-3-oxo-, methyl ester. Tryptophan-leucine-methionine,N(«alpha»,«epsilon»)-trifluoroacetyl-N-O-permethyl derivative. Ethylmorphine, trimethylsilyl ether. Buprenorphine. Dihydroergokryptine. Crinan-11-ol, 1,2-didehydro-3-methoxy-, (3«beta»,5«alpha»,11R,13«beta»,19«alpha»)-. [2,2'-Bimorphinan]-3,3',6,6'-tetrol, 7,7',8,8'-tetradehydro-4,5:4',5'-diepoxy-17,17'-dimethyl-, (5«alpha»,6«alpha»)-(5'«alpha»,6'«alpha»)-. Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5«alpha»,6«alpha»)-, bis(trifluoroacetate) (ester). Triazolo[4,5-d]pyrimidin-7-ol,3h-v-, 5-amino-3-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-, 5'-diphenyl phosphate (keto form). Deserpidine. Paclitaxel. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'«alpha»,10«alpha»)-. Ergotamine. Ergocristine. Codeine-propionyl.

Find more compounds similar to 4-(5-Ethylquinuclidine-2-carbonyl)-1,2-dihydro-2-oxoquinoline.

Sources

Note: Cheméo is only indexing the data, follow the source links to retrieve the latest data. The source is also providing more information like the publication year, authors and more. Take the time to validate and double check the source of the data.